Keywords: syntex, expects, patent, expiry, effects, first, quarter

SYNTEX EXPECTS PATENT EXPIRY EFFECTS

Article | 13 December 1993

Print This

The first quarter of fiscal year 1994 was good for US pharmaceutical company Syntex. Net income was $126.3 million, compared with a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in